Acadia Pharmaceuticals Stock Price - ACAD

-2.46 (-4.81%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-2.46 -4.81% 48.71 48.25 52.06 51.58 51.17 11:03:03
Bid Price Ask Price Spread Spread % News
48.69 48.75 0.06 0.12% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,654 314,311 $ 49.71 $ 15,625,471 1,220,110 21.56 - 54.60
Last Trade Time Type Quantity Stock Price Currency
11:03:03 100 $ 48.71 USD

Acadia Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.59B 155.86M 155.27M $ 339.08M $ -220.37M -1.60 -34.45
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 0.40%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week51.4553.0548.2551.63743,541-2.74-5.33%
1 Month51.5053.134344.2749.371,103,173-2.79-5.42%
3 Months42.7653.134330.0243.601,263,5095.9513.91%
6 Months47.7654.6030.0243.841,396,2960.951.99%
1 Year26.0954.6021.5639.041,512,24122.6286.7%
3 Years25.9954.6012.7727.001,883,23922.7287.42%
5 Years40.1354.6012.7728.841,906,0358.5821.38%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.